🔗 Share this article

Given that the US continues making historic changes to its vaccine schedules, one figure has surfaced unexpectedly: Dr. Tracy Beth Høeg, an American of Danish descent physician and public health researcher who rose to prominence by expressing skepticism about coronavirus shots throughout the pandemic and has focused upon potential deaths after Covid immunization in her brief position at the Food and Drug Administration.

Planned Changes to Pediatric Vaccine Program

Health officials planned to reveal major revisions to the pediatric vaccination calendar earlier this month, aligning the US with Denmark’s national calendar, sources say – a significant shift that would place the US out of alignment with much of the world with no evidence for public health gain. This reveal has been pushed back until the coming year.

Rather than Vinay Prasad, Dr. Høeg is scheduled to speak at the gathering. She was just designated temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to run the center this calendar year.

A New Direction at the FDA

The acting appointment may indicate a closer partnership between the drug and vaccine divisions as Dr. Høeg and Prasad solidify control at the regulatory agency – and it suggests a greater focus upon dismantling previously authorized immunizations at the FDA.

The new acting director has often pushed for halting some childhood vaccine recommendations in the US so as to align more like Denmark, a society with nationalized medicine and a number of inhabitants roughly the population of Wisconsin’s.

So far comments, she has kept her attention on immunizations – usually the domain of Dr. Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of medication approval.

Doubts Over Qualifications

Høeg has no apparent track record in pharmaceutical research, regulation or leadership, which has been typical for former heads of the Center for Biologics Evaluation and Research. She has served at the FDA as a top consultant to the FDA chief and the vaccine center since spring.

“She doesn’t seem to have the necessary background” for overseeing the CDER, remarked a neurologist and psychiatrist. “She lacks experience running a scientific study. She has no expertise in leading a major agency. She is not an expert in industry regulation.”

Past heads of CBER would “be deeply familiar with laws and regulations and the science of medication creation”, said Dr. Janet Woodcock. “Clearly, she lacks the type of experience that previous people who ran the center have had.”

This division has an enormous range of responsibilities at the FDA, she emphasized.

“Everybody just pays attention on the new drug program, but the off-patent medication office approves thousands of off-brand pharmaceuticals. There is also a biologic copycat branch, over-the-counter program and other areas, and all of those must be managed,” Dr. Woodcock noted. “The responsibility you overlook, that’s the thing that I always told people is going to cause problems.”

There is also, a substantial administrative element to the job, which manages in excess of 5,000 personnel. “It is a huge administrative position, if you execute it properly,” Woodcock added.

Agency Reaction and Controversial Programs

In response to inquiries about Høeg’s credentials and whether this assignment indicates increased cooperation among FDA leaders on immunizations, a spokesperson responded that the “questions stem from inaccurate presumptions”.

“Her experience aligns with the functions of her role,” the official stated, noting the time Høeg spent guiding the agency head on “medication safety and approval science, including predictive safety algorithms and vaccine surveillance”.

As acting director, Høeg inherits the agency head's controversial expedited review system, a contentious expedited therapy clearance system that apparently concerned her preceding directors. “By what process are these medications being chosen for this fast-track system? Who makes the choices?” Dr. Howard questioned. “There is a lot of confidentiality occurring at the regulatory body right now.”

Overall, he said, “the agency appears to be shifting towards more relaxed rules of pharmaceuticals, except for vaccines.”

Established Past Work on Vaccines

With immunizations, Høeg has a more established, if troubling, track record, some experts said. She authored a analysis using unverified public submissions to determine the incidence of heart inflammation following COVID-19 vaccination. She advised the state of Florida chief medical officer Joseph Ladapo, who reportedly have modified findings to indicate Covid vaccinations are more dangerous than they are.

Among her “policy goals” for the incoming administration encompassed revising regulations for recently developed shots and ending “optional” vaccines, she stated after the election on a audio program. At the FDA, Dr. Høeg has reportedly proposed preventing teenage boys from getting COVID-19 vaccinations.

“She’s an thorough dogmatist who starts off with her preconceived notions and reverse-engineers to fit the data in a very disingenuous, dishonest fashion,” Dr. Howard argued.

Consolidating Power and a “Campaign of Retribution”

Høeg became part of fellow contrarians, {like|